HCC Flashcards

1
Q

What are the 5 measures that make up the child Pugh score?

A
Bilirubin (<34 (1), 34-50 (2), >50 (3))
Albumin (>35 (1), 28-35 (2), <28 (3))
INR (<1.7 (1), 1.71-2.2 (2), >2.2 (3))
Ascites (nil (1), mild (2), severe (3))
Hepatic encephalopathy (nil (1), G1-2 or suppressed with meds (2), g3-4 (3))

Class A = 5-7
Class B = 7-9
Class C = >10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the vascular hallmark of HCC on dynamic imaging?

A

Hypervascularity in arterial phase with washout in portal venous phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What investigations should be performed in suspected HCC?

A

Medical hx & exam
FBC, renal, liver fx, bone profile, clotting,HBV, HCV serology and AFP
Dynamic contrast enhanced MRI
CT TAP
Biopsy (only if suitable for radical tx, can be omitted if cirrhosis and classic features on imaging)
Upper endoscopy (?varices)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What staging system can help to determine tx?

A

Barcelona clinic liver classification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the 1y survival for child’s-Pugh class A patients?

A

100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the 1y survival for child’s Pugh class B pts?

A

81%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the 1y survival for child’s Pugh class C pts?

A

45%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

If someone is child’s Pugh class C, what BCLC group are they in?

A

Stage D (BSC). MOS 3m

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If some one has portal vein invasion or nodal/distant mets but child’s Pugh class A and PS1, what BCLC group are they in?

A

Stage C - for systemic treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is first line systemic treatment for pts with advanced disease not suitable for ablative tx or TACE? (Providing child’s Pugh class A and good PS?)

A

Atezolizumab & bevacizumab

(Sorafenib if unable to receive immunotherapy)

1y OS 67%
MPFS 6.8m
(15% G3/4 hypertension)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is standard treatment for BCLC stage B?

A

TACE

1y OS 82%, 2y OS 63%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What criteria is used for suitability for liver transplantation?

A

Milan criteria

Single <5cm or upto 3 lesions up to 3cm, no extra hepatic disease, no vascular invasion

If fit these criteria, <10% recurrence, 70% 5y survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What segments of the liver are in the left lobe?

A

Segments 1-4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the 1y local control for microwave ablation? (For BCLC stage 0-A)

A

70-80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the maximum size of a liver lesion that would be considered for SABR?

A

5cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Is there any surveillance scheme for pts with cirrhosis?

A

Yes. USS and AFP every 6 months (or 4m is there is a <1cm lesion)

17
Q

What adjuvant therapy is given following a liver resection for HCC?

A

None, no evidence for adjuvant treatment

18
Q

How is hepatic encephalopathy graded?

A

Hepatic encephalopathy can be graded using the Conn score (also called West Haven classification) in which higher scores indicate a higher severity, as follows:
Grade 0: No personality or behavioural abnormality detected.
Grade 1: lack of awareness, euphoria or anxiety, shortened attention span, impaired performance of addition.
Grade 2: lethargy or apathy, minimal disorientation for time or place, subtle personality change, inappropriate behaviour, impaired performance of subtraction.
Grade 3: somnolence to semi stupor but responsive to verbal stimuli, confusion, gross disorientation.
Grade 4: coma (unresponsive to verbal or noxious stimuli).

Taken from: https://www.nice.org.uk/guidance/ta337/documents/hepatic-encephalopathy-maintenance-treatment-rifaximin-draft-scope-for-consultation2

19
Q

What is the 1 and 2y local control rate following SABR? (As per RIM meta analysis)

A

85.7% and 83.6% respectively